ANIP icon

ANI Pharmaceuticals

163 hedge funds and large institutions have $422M invested in ANI Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 46 increasing their positions, 54 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding:

more ownership

Funds ownership:

15% less repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 54

82% less call options, than puts

Call options by funds: $4.01M | Put options by funds: $22.4M

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
163
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$4.01M
Puts
$22.4M
Net Calls
Net Calls Change

Top Buyers

1 +$17.3M
2 +$6.09M
3 +$3.18M
4
MWNA
Marshall Wace North America
New York
+$3.02M
5
Nomura Holdings
Nomura Holdings
Japan
+$2.82M

Top Sellers

1 -$14.7M
2 -$9.24M
3 -$4.88M
4
Renaissance Technologies
Renaissance Technologies
New York
-$3.67M
5
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$3.31M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$82.1M
2
$31M
3
$29.4M
4
$24.3M
5
$18.8M
6
$18.3M
7
$18.3M
8
$15M
9
$12.3M
10
$10.3M
11
$9.39M
12
$9.21M
13
$7.32M
14
$6.09M
15
$6.03M
16
$4.96M
17
$4.32M
18
$4.17M
19
$3.96M
20
$3.44M
21
$3.42M
22
$3.28M
23
$3.18M
24
$3.02M
25
$2.89M